SENATE-BILL 3134: S.3134 - Combating Counterfeit Pharmaceuticals Act of 2025

Overall Constitutional Implications

SENATE-BILL 3134 raises significant constitutional concerns regarding individual rights, particularly in relation to access to healthcare and the potential for discriminatory enforcement. The bill's focus on combating counterfeit pharmaceuticals may inadvertently restrict access to legitimate medications, impacting various demographic groups disproportionately.

Key Individual Rights Affected

• Right to Health Care
• Due Process
• Equal Protection

Constitutional Provisions

• Fourteenth Amendment (Equal Protection Clause)
• Fifth Amendment (Due Process Clause)

Potential Constitutional Challenges

• Access to Medications: The bill could lead to shortages or increased difficulty in obtaining legitimate medications, potentially violating individuals' rights to health care.
• Discrimination: If enforcement disproportionately targets specific demographic groups, it could raise equal protection claims under the Fourteenth Amendment.
• Vagueness: Broad definitions within the bill may lead to arbitrary enforcement, infringing on individual rights without clear guidelines.

Summary

While the intent of SENATE-BILL 3134 is to enhance public health by combating counterfeit drugs, its implementation could infringe upon constitutional rights, particularly for marginalized communities. The bill must balance public safety with the protection of individual liberties, ensuring that access to necessary medications is not unduly restricted.